The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...

In the final days of the Biden administration, the U.S. Department of Health and Human Services’ Centers for Medicare and ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Biden adds Ozempic to list for Medicare price negotiationIn one of its last actions, the Biden ...

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.

The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...

Ozempic was one of the 15 drugs selected for the 2027 Medicare drug price negotiation program three days before ...

The Biden administration released another list of prescriptions drugs that would be subject to price controls. The price ...

Researchers from the University of California, Irvine, were the first to report an improvement in severe diabetes-related ...

Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...

Sanofi’s lofty position in diabetes has been undermined in the last few years by the loss of patent protection for its biggest-selling product Lantus (insulin glargine) and disappointing take-up ...

Some eye doctors were noticing a trend among patients that researchers in Europe now believe has been well demonstrated with data. Obesity and diabetes are strongly correlated—and, given the optical ...

Type 2 diabetes is a long-term, chronic medical condition. It develops mostly in adults but is becoming more common in children, according to the Centers for Disease Control and Prevention (CDC).